Brief: Globeimmune to delist and deregister common stock from Nasdaq Capital Market
05/07/2016 21:32
July 5 (Reuters) - Globeimmune Inc GBIM.O
* Globeimmune announces delisting and deregistration of
common stock from nasdaq capital market
Source text for Eikon: ID:nMKW8zxWMa
Further company coverage: GBIM.O
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on GlobeImmune
See all newsBrief: GlobeImmune announces updates
Brief: Globeimmune to delist and deregister common stock from Nasdaq Capital Market
Brief: GlobeImmune reports Q1 loss per share of $0.15
Brief: GlobeImmune hires Cantor Fitzgerald to assist in review of strategic alternatives
Brief: GlobeImmune says net income of $0.9 million for three months ended September 30, 2015